SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its Annual
Meeting of Shareholders on Tuesday, February 10, at 4:00 p.m. CT (5:00
p.m. ET).
Gary Maharaj, chief executive officer, Andy LaFrence, vice president of
finance and chief financial officer, and Scott Ward, chairman of the
board, will provide an overview of the broad outlook for the Company,
and discuss financial results and achievements for the fiscal year ended
September 30, 2014, as well as results from the first quarter of fiscal
year 2015.
To access the webcast, go to https://www.virtualshareholdermeeting.com/SRDX
five minutes prior to the start of the meeting to log in. In addition,
the Annual Meeting audio and slide presentation will be archived on the
Company’s website following the meeting.
About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance
the well-being of patients by providing the world’s foremost, innovative
surface modification technologies and in vitro diagnostic
chemical components. The Company partners with the world’s leading and
emerging medical device, diagnostic and life science companies to
develop and commercialize innovative products designed to improve
patient diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Copyright Business Wire 2015